Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,681 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention.
Tcheng JE, Gibson M, Krucoff MW, Patel MR, Ajit M, Hiremath J, Ponde C, Ramsaran E, Clark G, Lader AS, Beeuwkes R 3rd; SUPPORT-1 Investigators. Tcheng JE, et al. Among authors: gibson m. J Cardiovasc Pharmacol. 2020 Aug;76(2):189-196. doi: 10.1097/FJC.0000000000000830. J Cardiovasc Pharmacol. 2020. PMID: 32769849 Clinical Trial.
Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
Kaya MG, Akpek M, Lam YY, Yarlioglues M, Celik T, Gunebakmaz O, Duran M, Ulucan S, Keser A, Oguzhan A, Gibson MC. Kaya MG, et al. Among authors: gibson mc. Int J Cardiol. 2013 Sep 30;168(2):1154-9. doi: 10.1016/j.ijcard.2012.11.074. Epub 2012 Dec 5. Int J Cardiol. 2013. PMID: 23219132
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
De Luca G, Gibson M, Cutlip D, Huber K, Dudek D, Bellandi F, Noc M, Maioli M, Zorman S, Zeymer U, Secco GG, Mesquita Gabriel H, Emre A, Arntz HR, Rakowski T, Gyongyosi M, Hof AW; EGYPT Cooperation. De Luca G, et al. Among authors: gibson m. Arch Cardiovasc Dis. 2013 Mar;106(3):155-61. doi: 10.1016/j.acvd.2012.12.007. Epub 2013 Apr 2. Arch Cardiovasc Dis. 2013. PMID: 23582677 Free article.
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ, Spickler W, Théroux P, White H, Gibson M, Molhoek PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD. Peters RJ, et al. Among authors: gibson m. Am Heart J. 2001 Aug;142(2):237-43. doi: 10.1067/mhj.2001.116759. Am Heart J. 2001. PMID: 11479461 Clinical Trial.
Leveraging machine learning to enhance appointment adherence at a novel post-discharge care transition clinic.
Lee SY, Eagleson RM, Hearld LR, Gibson MJ, Hearld KR, Hall AG, Burkholder GA, McMahon J, Mahmood SY, Spraberry CT, Baker TJ, Garretson AR, Bradley HM, Mugavero MJ. Lee SY, et al. Among authors: gibson mj. JAMIA Open. 2024 Nov 9;7(4):ooae086. doi: 10.1093/jamiaopen/ooae086. eCollection 2024 Dec. JAMIA Open. 2024. PMID: 39524609 Free PMC article.
1,681 results